NS NursingSprint
ESC
Live search across the catalogue

Programs

ATI TEAS HESI A2 RN Nursing LPN Nursing Pre-Nursing
NGN Practice Study Notes Blog Log in Get started

RN Nursing · Cardiovascular Disorders

Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE): Nursing Study Guide

By Marcus · Updated May 26, 2026

A comprehensive nursing study guide on DVT and PE, covering risk factors, clinical presentation, Wells scoring, diagnostics, anticoagulation therapy, nursing care, and NCLEX high-yield pearls.

On this page

Deep vein thrombosis (DVT) and pulmonary embolism (PE) together make up venous thromboembolism (VTE) — one of the highest-yield emergency topics on the NCLEX. This guide walks through pathophysiology, risk factors, diagnostics, treatment, and nursing priorities for both conditions, plus common test traps.

What Is DVT?

  • Deep vein thrombosis is a blood clot that forms in the deep veins, most commonly in the lower extremities.
  • DVT is part of venous thromboembolism (VTE), along with pulmonary embolism.
  • Prompt diagnosis and treatment are essential to prevent life-threatening complications.

DVT Risk Factors (Virchow's Triad)

  • Venous stasis: immobility, prolonged travel, bed rest, recent surgery, obesity.
  • Vascular injury: trauma, surgery, fractures, IV catheters, previous DVT.
  • Hypercoagulability: cancer, pregnancy, oral contraceptives, inherited clotting disorders, smoking.

DVT Clinical Presentation

  • Unilateral leg pain, swelling, and warmth are the most common symptoms.
  • The affected leg may appear red or discolored compared with the unaffected side.
  • Patients may report a feeling of heaviness or fullness in the calf or thigh.
  • A low-grade fever may be present.
  • Homan's sign (calf pain with foot dorsiflexion) is NOT reliable for diagnosis.

DVT Diagnostic Approach

Wells Score for DVT

Clinical Feature Points
Active cancer +1
Paralysis, paresis, or recent plaster immobilization +1
Recently bedridden >3 days or major surgery within 12 weeks +1
Localized tenderness along distribution of deep veins +1
Entire leg swollen +1
Calf swelling >3 cm compared to asymptomatic leg +1
Pitting edema confined to symptomatic leg +1
Collateral superficial (non-varicose) veins +1
Previously documented DVT +1
Alternative diagnosis as likely or more likely than DVT -2
  • Score ≥ 2: DVT likely → proceed directly to ultrasound.
  • Score ≤ 1: DVT unlikely → check D-dimer first.

D-Dimer Testing

  • A negative D-dimer (<0.50 µg/mL) rules out DVT in low-risk patients.
  • A positive D-dimer requires ultrasound confirmation.
  • D-dimer is sensitive but not specific — it can be elevated in many conditions.

Imaging

  • Venous duplex ultrasound is the first-line imaging method for DVT.
  • It is noninvasive, highly accurate, and visualizes clot location.

DVT Treatment

Anticoagulation is the cornerstone of treatment. Note: anticoagulation does NOT dissolve clots — it prevents extension and allows the body to dissolve them.

Drug Class Examples Dosing NCLEX Pearl
DOACs (preferred) Apixaban (Eliquis) 10 mg BID × 7 days, then 5 mg BID No routine monitoring; fewer drug interactions
Rivaroxaban (Xarelto) 15 mg BID × 21 days, then 20 mg daily Take with food
LMWH Enoxaparin (Lovenox) 1 mg/kg BID or 1.5 mg/kg daily Preferred in pregnancy and cancer
Unfractionated heparin IV heparin Bolus then infusion titrated to aPTT Monitor aPTT; reversed with protamine
Warfarin Coumadin Initial heparin bridge; INR 2–3 Monitor INR; antidote is vitamin K

Treatment Duration

  • Provoked DVT (surgery, trauma): 3 months.
  • Unprovoked DVT: at least 3 months; often extended.
  • Cancer-associated DVT: 3–6 months minimum; DOACs preferred.
  • Recurrent DVT or high-risk thrombophilia: lifetime treatment.

DVT Nursing Care

  • Measure and compare bilateral calf circumferences daily.
  • Do NOT massage the affected leg — this can dislodge the clot.
  • Elevate the affected extremity above heart level to reduce edema.
  • Apply warm compresses for comfort.
  • Administer anticoagulants and monitor for bleeding.
  • Apply compression stockings to prevent post-thrombotic syndrome.
  • Encourage ambulation once anticoagulation is therapeutic.

DVT Complications

Complication Description Exam Alert
Pulmonary embolism (PE) Clot travels to the lungs; most dangerous complication Sudden dyspnea, chest pain, hypoxia — life-threatening
Post-thrombotic syndrome Chronic venous insufficiency after DVT Chronic pain, swelling, skin changes, ulceration; prevent with compression stockings
Phlegmasia cerulea dolens Severe DVT with venous gangrene Massive swelling, pain, cyanosis; limb-threatening
Recurrent DVT New clot despite treatment Higher risk in unprovoked DVT; may need extended anticoagulation
Bleeding From anticoagulation Monitor and teach bleeding precautions

What Is Pulmonary Embolism?

  • PE occurs when a DVT dislodges and travels to the lungs, blocking a pulmonary artery.
  • Causes ventilation–perfusion mismatch, hypoxemia, and increased pulmonary vascular resistance.
  • Large emboli can cause right ventricular failure and hemodynamic collapse.
  • PE is a life-threatening emergency with high mortality if not promptly treated.

PE Clinical Presentation

Symptoms

  • Sudden-onset dyspnea is the most common symptom.
  • Pleuritic chest pain (sharp pain with breathing) in about 50% of patients.
  • Cough, hemoptysis, anxiety, sense of doom.
  • Syncope can occur with massive PE.
  • Unilateral leg swelling from the source DVT.

Physical Findings

  • Tachypnea, tachycardia, hypoxemia are common.
  • Decreased breath sounds, crackles, or wheezes may be heard.
  • Signs of right heart failure (JVD, hepatomegaly, edema) in massive PE.

PE Risk Stratification

Risk Category Definition Management
High-risk (massive PE) Hemodynamically unstable (SBP <90 mmHg or drop >40 mmHg) Emergent reperfusion (thrombolytics or embolectomy)
Intermediate-risk (submassive PE) Stable with RV dysfunction or elevated troponin Anticoagulation; monitor closely
Low-risk (small PE) Stable, no RV dysfunction, normal troponin Anticoagulation; may be outpatient

PE Diagnostic Approach

Wells Score for PE

  • Score > 4: PE likely → proceed directly to CTPA.
  • Score ≤ 4: PE unlikely → check D-dimer first.

D-Dimer Testing

  • Negative D-dimer rules out PE in low-risk patients.
  • Positive D-dimer requires CTPA confirmation.

Imaging

  • CT pulmonary angiography (CTPA) is the preferred study.
  • V/Q scan is an alternative if CTPA is contraindicated.

PE Treatment

Stable PE (Low- and Intermediate-Risk)

  • Anticoagulation is the mainstay.
  • Same options and durations as DVT.

Massive PE (High-Risk with Hemodynamic Instability)

First actions:

  • Assess ABCs, give high-flow oxygen, establish IV access.
  • Give cautious IV fluids (≤500 mL bolus) — avoid volume overload.
  • Start vasopressors (norepinephrine) if needed.

Reperfusion therapy:

  • Thrombolytics (tPA, alteplase) are life-saving in massive PE.
  • If thrombolytics are contraindicated or fail → embolectomy.

Contraindications to thrombolytics: active bleeding, recent stroke, recent major surgery, severe hypertension.

PE Nursing Care

  • Monitor vital signs continuously (BP, HR, RR, SpO₂).
  • Assess chest pain and respiratory status.
  • Watch for signs of right heart failure: JVD, edema.
  • Administer oxygen to maintain SpO₂ > 92%.
  • Position patient in semi-Fowler's to high-Fowler's.
  • Administer anticoagulants; monitor for bleeding.
  • With thrombolytics, monitor closely for bleeding.

Patient Teaching for VTE

  • Take anticoagulants exactly as prescribed; never skip doses.
  • Report signs of bleeding: dark stools, coffee-ground vomit, unusual bruising.
  • Use a soft toothbrush and electric razor.
  • Wear medical alert identification.
  • Avoid prolonged sitting or standing.
  • Move legs frequently on long trips and stay well hydrated.
  • Wear compression stockings as prescribed.
  • Report new leg swelling, pain, redness, or sudden shortness of breath.

Common NCLEX Traps

  • Never massage a DVT leg — can dislodge the clot and cause PE.
  • Homan's sign is not reliable for DVT diagnosis.
  • D-dimer is sensitive but not specific; a positive result requires imaging.
  • Wells score determines the testing path, not the diagnosis itself.
  • Anticoagulation does not dissolve clots — it prevents extension.
  • DOACs are first-line for most patients, including many with cancer.
  • Thrombolytics are only for massive/unstable PE.
  • Warfarin requires a heparin bridge until INR is therapeutic.
  • In pregnancy, use LMWH — DOACs are contraindicated.

Key Takeaways

  • DVT presents with unilateral leg swelling, pain, and warmth; use Wells score to decide between ultrasound and D-dimer.
  • Anticoagulation is the cornerstone of DVT/PE treatment — DOACs are first-line for most patients, LMWH preferred in pregnancy and cancer.
  • Never massage a DVT leg; elevate the extremity and apply compression stockings.
  • PE = sudden dyspnea, pleuritic chest pain, hypoxia; diagnose with Wells score → CTPA or D-dimer.
  • Massive PE (SBP <90 mmHg) requires thrombolytics or embolectomy; stable PE is treated with anticoagulation.
  • Teach patients bleeding precautions, medication adherence, and to report new leg swelling or sudden shortness of breath.

Test yourself on Peripheral Vascular Disorders

427 practice questions, each with a full teaching rationale.

Practise free